E-LIB Suche - Ergebnisse für: Scheithauer, W.

1

Consensus molecular subgroups (CMS) of colorectal cancer (C..:

Stintzing, S. ; Wirapati, P. ; Lenz, H.-J....
Annals of Oncology. 30 (2019) 11 - p. 1796-1803 , 2019

Link: https://doi.org/10.1093/..

2

Relevance of baseline carcinoembryonic antigen for first-li..:

Holch, J.W. ; Ricard, I. ; Stintzing, S....
European Journal of Cancer. 106 (2019) - p. 115-125 , 2019

Link: https://doi.org/10.1016/..

3

Evaluation of survival across several treatment lines in me..:

Modest, D.P. ; Ricard, I. ; Stintzing, S....
European Journal of Cancer. 84 (2017) - p. 262-269 , 2017

Link: https://doi.org/10.1016/..

4

Impact of BRAF and RAS mutations on first-line efficacy of ..:

Stintzing, S. ; Miller-Phillips, L. ; Modest, D.P....
European Journal of Cancer. 79 (2017) - p. 50-60 , 2017

Link: https://doi.org/10.1016/..

5

MONDTI: Molecular characterisation platform for identifying..:

Kieler, M. ; Warzecha, A. ; Müllauer, L....
European Journal of Cancer. 69 (2016) - p. S135 , 2016

Link: https://doi.org/10.1016/..

6

447 Extended Analysis for Cancer Treatment (EXACT): Interim..:

Prager, G. ; Unseld, M. ; Waneck, F....
European Journal of Cancer. 51 (2015) - p. S94 , 2015

Link: https://doi.org/10.1016/..

7

nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic C..:

Goldstein, D. ; El-Maraghi, R. H. ; Hammel, P....
JNCI Journal of the National Cancer Institute. 107 (2015) 2 - p. dju413-dju413 , 2015

Link: https://doi.org/10.1093/..

8

2089 Response to chemotherapy allows to identify mCRC patie..:

Scheithauer, W. ; Riera-Knorrenschild, J. ; Kopp, H.G....
European Journal of Cancer. 51 (2015) - p. S357-S358 , 2015

Link: https://doi.org/10.1016/..

9

Microparticle-associated tissue factor activity, venous thr..:

THALER, J. ; AY, C. ; MACKMAN, N....
Journal of Thrombosis and Haemostasis. 10 (2012) 7 - p. 1363-1370 , 2012

Link: https://doi.org/10.1111/..

10

6132 POSTER Efficacy of Panitumumab Plus FOLFIRI Versus FOL..:

Price, T. ; Peeters, M. ; Strickland, A....
European Journal of Cancer. 47 (2011) - p. S431-S432 , 2011

Link: https://doi.org/10.1016/..

11

Thrombosis risk and survival in cancer patients with elevat..:

KANZ, R. ; VUKOVICH, T. ; VORMITTAG, R....
Journal of Thrombosis and Haemostasis. 9 (2011) 1 - p. 57-63 , 2011

Link: https://doi.org/10.1111/..

12

253 INVITED Tailored Adjuvant Chemotherapy According to Pat..:

Scheithauer, W.
European Journal of Cancer. 47 (2011) - p. S59-S60 , 2011

Link: https://doi.org/10.1016/..

13

Colorectal cancer – ASCO 2010:

Scheithauer, W.
memo - Magazine of European Medical Oncology. 3 (2010) 4 - p. 155-156 , 2010

Link: https://doi.org/10.1007/..

14

Plasma disposition of capecitabine and its metabolites 5′DF..:

Czejka, Martin ; Schueller, J. ; Farkouh, A...
Cancer Chemotherapy and Pharmacology. 67 (2010) 3 - p. 613-619 , 2010

Link: https://doi.org/10.1007/..

15

VEGF and EGFR inhibition: opening a new door to cancer trea..:

Scheithauer, W. ; Pirker, R. ; Grünberger, T..
European Surgery. 42 (2010) 1 - p. 24-28 , 2010

Link: https://doi.org/10.1007/..